The American Journal of Medicine
Volume 121, Issue 5 , Pages 406-418, May 2008

Association Between Alcohol Consumption and Both Osteoporotic Fracture and Bone Density

  • Karina M. Berg, MD, MS

      Affiliations

    • Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
    • Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
    • Corresponding Author InformationRequests for reprints should be addressed to Karina M. Berg, MD, MS, Montefiore Medical Center, Division of General Internal Medicine, 111 East 210th Street, Bronx, NY 10467.
  • ,
  • Hillary V. Kunins, MD, MS, MPH

      Affiliations

    • Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
    • Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
  • ,
  • Jeffrey L. Jackson, MD, MPH

      Affiliations

    • Uniformed Services University, Bethesda, Md
  • ,
  • Shadi Nahvi, MD

      Affiliations

    • Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
    • Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
  • ,
  • Amina Chaudhry, MD, MPH

      Affiliations

    • Johns Hopkins University, Baltimore, Md.
  • ,
  • Kenneth A. Harris Jr, MD, PhD

      Affiliations

    • Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
    • Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
  • ,
  • Rubina Malik, MD, MS

      Affiliations

    • Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
  • ,
  • Julia H. Arnsten, MD, MPH

      Affiliations

    • Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
    • Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY

Article Outline

Abstract 

Objective

Alcoholism is a risk factor for osteoporotic fractures and low bone density, but the effects of moderate alcohol consumption on bone are unknown. We performed a systematic review and meta-analysis to assess the associations between alcohol consumption and osteoporotic fractures, bone density and bone density loss over time, bone response to estrogen replacement, and bone remodeling.

Methods

MEDLINE, Current Contents, PsychINFO, and Cochrane Libraries were searched for studies published before May 14, 2007. We assessed quality using the internal validity criteria of the US Preventive Services Task Force.

Results

We pooled effect sizes for 2 specific outcomes (hip fracture and bone density) and synthesized data qualitatively for 4 outcomes (non-hip fracture, bone density loss over time, bone response to estrogen replacement, and bone remodeling). Compared with abstainers, persons consuming from more than 0.5 to 1.0 drinks per day had lower hip fracture risk (relative risk=0.80 [95% confidence interval, 0.71-0.91]), and persons consuming more than 2 drinks per day had higher risk (relative risk=1.39 [95% confidence interval, 1.08-1.79]). A linear relationship existed between femoral neck bone density and alcohol consumption. Because studies often combined moderate and heavier drinkers in a single category, we could not assess relative associations between alcohol consumption and bone density in moderate compared with heavy drinkers.

Conclusion

Compared with abstainers and heavier drinkers, persons who consume 0.5 to 1.0 drink per day have a lower risk of hip fracture. Although available evidence suggests a favorable effect of alcohol consumption on bone density, a precise range of beneficial alcohol consumption cannot be determined.

Keywords: Alcohol, Bone mineral density, Hip fracture, Meta-analysis, Osteoporosis

 

The prevalence of low bone density among men and women aged more than 50 years has been estimated at greater than 44 million.1 In this population, 1 in 2 women and 1 in 4 men develop osteoporotic fractures.2 In addition to unmodifiable risk factors such as age and sex, bone density is influenced by modifiable lifestyle factors, including alcohol consumption.

Clinical Significance

 


Compared with abstinence, consuming 1 drink or less per day is associated with a lower risk of hip fracture, whereas consuming more than 2 drinks per day is associated with higher hip fracture risk.

Greater alcohol consumption (up to 2 drinks per day) is linearly associated with higher bone density.

Available literature is insufficient to determine the precise range of alcohol consumption that would maximize bone density and minimize hip fracture risk.

Chronic heavy alcohol consumption is widely considered a risk factor for osteoporotic fractures and low bone density.2 However, this relationship is based on small studies of men3, 4, 5, 6, 7 and has not been established in women.8 In contrast, several studies have reported that moderate alcohol use may decrease fracture rates and increase bone density.9, 10, 11, 12, 13, 14, 15, 16, 17, 18 In 2001, a National Institutes of Health panel concluded that “alcoholism” is a cause of osteoporosis but that “consumption of alcoholic beverages” has an inconsistent effect on bone.19

We performed a systematic review and meta-analysis to assess the associations between alcohol consumption and osteoporotic hip and non-hip fractures, bone density and bone density loss over time, bone response to estrogen replacement, and bone remodeling. Our secondary aim was to examine whether the effect of alcohol on these outcomes is modified by sex.

Back to Article Outline

Materials and Methods 

Search Strategies 

On May 14, 2007, we searched all Ovid MEDLINE databases, the Cochrane Central Register of Controlled Trials, Current Contents Connect, and PsychINFO. We defined search terms for alcohol consumption and each outcome (Appendix), and limited the results to human subjects and English language. We then manually searched references of included studies and pertinent reviews.

Study Selection 

Two reviewers independently assessed each citation using predefined criteria. Included studies had experimental, cohort, or case-control designs; included adults both exposed and not exposed to alcohol; and reported on at least 1 outcome. We excluded studies in which alcohol consumption and bone density were measured once at the same point in time to avoid invalid assumptions about temporal sequence. To examine osteoporotic fracture rate, we identified studies of low-impact fractures of the hip, wrist, forearm, or vertebra. To evaluate bone density, we sought prospective studies in which bone density was assessed by central dual energy x-ray absorptiometry and measured after alcohol exposure. Studies examining bone density loss over time required bone density measures at 2 points in time. To examine the outcome of bone response to estrogen, we identified studies reporting the effect of alcohol on osteoporotic fracture rates or bone density among postmenopausal women taking estrogen replacement therapy. For the final outcome, bone remodeling, we included studies examining markers of bone formation and resorption (Appendix). Abstract ratings between reviewers had 92% agreement (κ=0.73). Disagreements were resolved by discussion.

Assessment of Study Quality 

We assessed study quality using the internal validity criteria of the US Preventive Services Task Force,20 assigning a rating of “good” when all criteria were met, “fair” when 1 or more criterion was partially met and the study contained no fatal flaws, and “poor” if 1 or more criterion was not met and a fatal flaw invalidated the results. Studies of poor quality were excluded.

For our systematic review, studies were rated “good” if alcohol consumption was reported as a rate (eg, “drinks per day”) and reflected data from more than a single survey item (ie, from separate questions about consumption of beer, wine, or spirits). Studies that used a single survey item, or did not sufficiently explain their measures, were rated “fair.” Studies that used imprecise definitions of alcohol consumption (eg, “ever,” “daily,” or “yes”) were rated “poor.” In addition, we rated studies on the timing of their measurement of alcohol consumption. Prospective studies were rated “good” if alcohol consumption was measured at multiple time points and “fair” if alcohol consumption was measured at baseline only.

Prospective studies were rated “good” if fractures were ascertained by more than 1 source of information (eg, self-report verified by hospital records or a sample of specific International Classification of Diseases codes validated by chart review) and “fair” if only 1 information source was used. Case-control studies were rated “good” if cases were established using hospital records and “fair” if they were established by other means.

For all studies, we developed a predefined set of potential confounders that included age, body mass index, smoking, dietary calcium, physical activity, and estrogen exposure. “Good” studies adjusted for all potential confounders, “fair” studies adjusted for some confounders, and “poor” studies adjusted for age only. Differences were discussed until agreement was reached. Quality ratings between reviewers had 85% agreement (κ=0.67).

Data Extraction 

The first author (KMB) and 1 other author met to extract quantitative data on the association between alcohol consumption and the outcome, and adjustment for potential confounders. For example, data extracted may include the odds of hip fracture among those who consumed more than 0.4 drinks per day compared with abstainers (odds ratio=0.69; 95% confidence interval [CI], 0.53-0.90), after adjusting for age, body mass index, smoking, and estrogen therapy.21 One investigator was contacted by the first author to request numeric data that corresponded to a figure in the original study.22 Because studies reported alcohol consumption using numerous units of measurement, we converted alcohol consumption into drinks per day by estimating that each standard drink is equivalent to 14 g or 0.6 fluid oz of pure alcohol,23 that there are 29 kJ/g of alcohol,24 and that 1 unit of alcohol equals 8 g of pure alcohol.25

Data Synthesis 

For pooled estimates of the effect of alcohol consumption on hip fracture incidence, we extracted relative risk (RR) data, created strata of alcohol use, and performed a dose-response analysis using mean drinks per day when studies reported ranges of alcohol consumption. For the few studies that reported multiple categories of alcohol consumption within 1 defined strata, we “pooled first” using inverse variance weights. Given the rarity of events, RRs and odds ratios for hip fractures were considered equivalent. We combined fracture data by log transforming reported effects in each stratum and then pooled data with the random effects models.26 Sex-stratification of the analysis of alcohol consumption and hip fracture was not possible because only 1 study reported results by sex.

For bone density, we pooled data using a dose-response regression model with adjustment for clustering within studies using inverse variance as analytic weights.27 When necessary, we imputed variance using the method of Follman et al.28 For each outcome, when no upper limit was given for the highest category of alcohol consumption, we multiplied the reported limit by 1.5, a method used in a similar meta-analysis.29 We were unable to perform a meta-analysis of bone density loss over time because of the disparate outcomes reported (eg, beta-coefficient for the effect of alcohol on bone density loss, annual rate of bone density loss, or percentage of bone density loss). The results were not significantly different for men and women for any outcome except bone density loss over time.

Heterogeneity was assessed using the Q and I2 statistics. Publication bias was assessed using the method of Egger et al.30 All meta-analyses were performed using STATA (STATA 9.2, College Station, Tex).

Back to Article Outline

Results 

Overview of the Evidence Base 

The results of our search strategy are illustrated in Figure 1. Most studies were conducted in white, European, or American adults aged more than 50 years. The results were commonly adjusted for age, body mass index, and smoking. However, few studies adjusted for dietary calcium, physical activity, or estrogen exposure.

Alcohol Consumption and Hip Fracture Risk 

Eight of 13 studies that examined the association between alcohol consumption and risk of hip fracture were prospective cohort studies,33, 34, 35, 36, 37, 38, 39, 40 and 5 were case-control studies21, 31, 32, 41, 42 (Table 1). The case-control studies compared hospitalized cases with community controls,21, 32, 41 hospitalized controls,42 or both.31 Cases and controls were matched on age, sex, race or ethnicity, and residential area,31, 32 or geographic location only.21, 41, 42

Table 1. Studies of the Association between Alcohol Consumption and Risk of Hip Fracture
Study, yearStudy DesignSample CharacteristicsStudy QualityDuration of Follow-upTiming of Measurement of Alcohol UseEventsPotential Confounders Adjusted for in AnalysisUnit of Analysis of AlcoholMagnitude of Association (95% CI)
Felson, 1988 (34)Framingham Study cohort5209 adults, aged 31–95 yrsfair117,224 person-yearsBaseline and years 4, 10, 20, 22, 24, 26, and 30217Age, sex, weight, smokingper 7 oz/wkOdds Ratio: 1.28 (1.05–1.56)
Hoidrup (men), 1999 (35)Combined data from three cohort studies17,868 men, aged 20–93 yrsfair434,324 person-yearsBaseline and between 1 and 3 follow up interviews307Age, BMI, smoking, physical activity, original cohort, education, cohort of origin
<0.1 drinks/day

0.1–0.9 drinks/day

1–1.9 drinks/day

2–3.9 drinks/day

4–5.9 drinks/day

6–9.9 drinks/day

>10 drinks/day


Relative Risk: 1.00

0.89 (0.58-1.38)

0.84 (0.54-1.30)

0.84 (0.54-1.32)

1.74 (1.06-2.89)

1.84 (1.00-3.41)

5.28 (2.60-10.70)

Hoidrup (women), 1999 (35)Combined data from three cohort studies13,917 women, aged 20–93 yrsfair434,324 person-yearsBaseline and between 1 and 3 follow up interviews500Age, BMI, smoking, physical activity, original cohort, education, cohort of origin
<0.1 drinks/day

0.1–0.9 drinks/day

1–1.9 drinks/day

2–3.9 drinks/day

>4 drinks/day


Relative Risk: 1.00

0.89 (0.71–1.12)

1.01 (0.77–1.33)

1.32 (0.92–1.87)

1.01 (0.37–2.75)

Kanis, 2004 (36)Combined data from three cohort studies16,971 adults, aged 25–103 yrsfair75,433 person-yearsUnspecified279BMD
0.6 drinks/day

>1.1 drinks/day)

>1.7 drinks/day

>2.3 drinks/day


Relative Risk: 1.00

1.70 (1.20–2.42

2.05 (1.35–3.11)

2.39 (1.39–4.09)

Holbrook, 1988 (37)Rancho Bernando cohort957 adults, aged 50–79 yrsfair14 yearsBaseline33Age, sex, BMI, smokingper 0.9 drinks/dayRelative Risk: 1.00
Hemenway, 1994 AmJPubHealth (38)Health Professionals Follow-Up Study cohort49,895 men, aged 40–75 yrsfair270,000 person-yearsBaseline67Age, BMI, smoking, height
0 drinks/day

0–1.1 drinks/day

1.1–2.1 drinks/day

>2.1 drinks/day


Relative Risk: 1.00

1.06 (0.58–1.93)

0.95 (0.42–2.17)

0.91 (0.38–2.17)

Hernandez-Avila, 1991 (39)Nurses Health Study cohort84,484 women, aged 29–74 yrsfair482,347 person-yearsBaseline65Age, BMI, menopausal status, estrogen therapy, calcium use, caffeine exposure
0 drinks/day

0–0.4 drinks/day

0.4–1.1 drinks/day

1.1–1.8 drinks/day

≥1.8 drinks/day


Relative Risk: 1.00

0.94 (0.35–2.68)

1.99 (0.97–4.07)

1.15 (0.51–2.61)

2.33 (1.18–4.57)

Hansen, 2000 (40)Iowa Women's Health Study cohort34,703 women, aged 55–69 yrsfair§187,035 person-yearsBaseline275Age, BMI, smoking, physical activity, estrogen therapy, calcium use, caffeine exposure, calories, waist:hip ratio
0 drinks/day

<0.3 drinks/day

≥0.3 drinks/day


Relative Risk: 1.00

0.92 (0.68–1.24)

0.79 (0.57–1.10)

Mukamal, 2007 (33)Cardiovascular Health Study cohort5865 adults, aged ≥65 yrsfair70,380 person-yearsBaseline and annually for 9 or 10 years412Age, sex, smoking, weight, height, leisure time physical activity, difficulty arising from a bed or chair, estrogen therapy, thiazide type diuretics, thyroid agents, race, diabetes, hypertension, cardiovascular disease, visual problems, arthritis, previous cancer, weight in early teens, Mini-Mental Status Exam score
0 drinks/day

former drinkers

<0.14 drinks/day

0.14–0.86 drinks/day

1–1.86 drinks/day

≥2 drinks/day


Hazard Ratio 1.00

0.84 (0.50–1.43)

0.77 (0.61–0.98)

0.83 (0.61–1.12)

0.82 (0.53–1.26)

1.20 (0.74–1.95)

Cumming, 1994 (41)Case-control416 adults, aged 65–100 yrs (209 cases, 207 controls)fairNANANAAge, sex
0 drinks/day

<1 drinks/day

≥1 drinks/day


Odds Ratio: 1.00

0.70 (0.50–1.20)

0.60 (0.30–1.30)

Baron, 2001 (21)Case-control4589 postmenopausal women (1,327 cases, 3,262 controls)fairNANANAAge, BMI, smoking, estrogen therapy
nondrinkers

drinkers

<0.2 drinks/day

0.2–0.4 drinks/day

>0.4 drinks/day


Odds Ratio: 1.00

0.70 (0.60–0.82)

0.72 (0.59–0.88)

0.70 (0.56–0.87)

0.69 (0.53–0.90)

Grisso, 1994 (31)Case-control543 black women (144 cases, 399 controls)fairNANANAAge, BMI, area of residence
0–0.1 drinks/day

0.1–0.9 drinks/day

≥1 drinks/day


Odds Ratio: 1.00

1.3 (0.6–2.9)

2.2 (0.9–5.7)

La Vecchia, 1991 (42)Case-control1658 women, aged 29–74 yrs (209 cases, 1449 controls)fairNANANAAge, BMI, smoking, estrogen therapy, education, area of residence
0 drinks/day

<2 drinks/day

–3 drinks/day

>3 drinks/day


Relative Risk: 1.00

0.7 (0.50–1.10)

1.2 (0.80–1.80)

1.0 (0.50–1.80)

Suzuki, 1997 (32)Case-control747 adults, aged 65–89 yrs (249 cases, 498 controls)fairNANANABMI, physical activity, coffee and green tea, rural residence, main work activity, sleep disturbance, CVA hemiplegia, DM, milk, fish, sun exposure, immobilization, difficulty bathing independently, type of bed
0 drinks/day

<1.9 drinks/day

≥1.9 drinks/day


Odds Ratio: 1.00

0.51 (0.29–0.89)

0.77 (0.33–1.79)

Incomplete adjustment for potential confounders (age, body mass index, smoking, dietary calcium, physical activity, and estrogen exposure in women).

alcohol consumption measured at baseline only (prospective studies).

1 survey item to measure alcohol consumption or poor explanation of measurement methods

§fractures ascertained from a single source (prospective studies); II cases not established using hospital records (case-control studies); NA indicates not applicable; BMI indicates body mass index; CVA indicates cerebrovascular accident; DM indicates diabetes mellitus; “Former drinkers” defined as participants who reported abstinence at baseline but at a follow-up visit responded “yes” to either a “change in pattern of drinking in the past 5 years” or “ever regularly consumed ≥ drinks daily”.

Gaps in categories due to conversion from drinks per week to drinks per day.

Meta-analysis of the effect of alcohol consumption on hip fracture risk revealed a J-shaped relationship, which is illustrated in Figure 2. Compared with abstainers, we found a lower risk of hip fracture among persons consuming up to 0.5 drinks per day (RR=0.84 [95% CI, 0.70-1.01] Q=091, I2=0.00, publication bias P=.39) and persons consuming from more than 0.5 to 1 drink per day (RR=0.80 [95% CI, 0.71-0.91] Q=12.66, I2=0.21, publication bias P=.43). Those consuming from more than 1 to 2 drinks per day did not differ from abstainers (RR=0.91 [95% CI, 0.76-1.09] Q=11.33, I2=0.24, publication bias P=.72), and persons consuming more than 2 drinks per day had a higher risk of hip fracture (RR=1.39 [95% CI, 1.08-1.79] Q=6.73, I2=0.24, publication bias P=.38).

  • View full-size image.
  • Figure 2. 

    Association between alcohol consumption and hip fracture risk. Reference exposure is zero drinks per day. Size of data marker represents sample size. Horizontal lines denote 95% confidence intervals.

Alcohol Consumption and Fracture of the Forearm, Wrist, or Vertebrae 

Of the 3 cohort studies that examined the effect of alcohol consumption on fracture of the forearm or wrist, 2 found no significant association40, 43 and 1 found that women consuming 1.8 drinks or more per day had a higher risk of wrist fracture compared with abstainers (RR 1.38 [95% CI, 1.09-1.74]).39 Two studies examined the relationship between alcohol consumption and risk of vertebral fracture; 1 found no significant association,40 and 1 found increased odds of fracture among men who consumed more than 0.3 drinks per day compared with abstainers (adjusted odds ratio 4.61 [1.19-17.90]).44

Alcohol Consumption and Bone Density 

Four cohort studies assessed the association between alcohol consumption and bone density (Table 2).12, 13, 16, 33 Overall, there was a linear relationship between femoral neck bone density and alcohol consumption (Figure 3). Each drink per day was associated with an increase in femoral neck bone density of 0.045g/cm2 (95% CI, 0.008-0.082 g/cm2, P=.01). A significant linear relationship also was found at the vertebral spine (data not shown).

Table 2. Studies of the Association between Alcohol Consumption and Bone Mineral Density
Study, YearSample CharacteristicsStudy QualityDuration of Follow-upMeasurement of Alcohol ConsumptionOutcome MeasurePotential Confounders Adjusted for in AnalysisStatistical Measure of AssociationUnit of Analysis of AlcoholBMD (g/cm2)p Value
Mukamal, 2007 (33)5865 adults, aged ≥ 65 yrsfair12 yearsBaseline and annually for 9 or 10 yearsfemoral neck BMDAge, sex, smoking, weight, height, leisure time physical activity, difficulty arising from a bed or chair, estrogen therapy, thiazide type diuretics, thyroid agents, race, diabetes, hypertension, cardiovascular disease, visual problems, arthritis, previous cancer, weight in early teens, Mini-Mental Status Exam scoreF-tests
0 drinks/day

former drinkers

<0.14 drinks/day

0.14–0.86 drinks/day

1–1.86 drinks/day

≥ 2 drinks/day


0.69

0.72

0.69

0.70

0.73

0.74

<0.001
Holbrook et al. (Rancho Bernando), 1993 (13)267 women, mean age 60 yrsfair12 yrsBaseline and year 12femoral neck BMDAge, smoking, BMI, exercise and estrogen therapyχ2
0 drinks/day

<0.5 drinks/day

0.5–1.2 drinks/day

>1.2 drinks/day


0.64

0.63

0.62

0.64

NS
Felson et al. (Framingham Study), 1995 (12)1,154 adults, aged 68–96 yrs (data shown for women)fair20 yrsBaseline and years 2, 4, 6, 8, 10, 12, 14, and 16femoral neck BMDAge, smoking, weight, height, age at menopause, durat ion of estrogen useχ2
<0.2 drinks/day

0.2–0.4 drinks/day

0.7–1.4 drinks/day

≥1.7 drinks/day


0.71

0.70

0.71

0.74

NS
Feskanich et al. (Nurses' Health Study), 1999 (16)188 women, aged 50–74fair14 yrsBaseline and years 4, 6, and 10femoral neck BMDAge, smoking, BMI, estrogen therapy, age at menopauseχ2
<0.3 drinks/day

0.3–0.8 drinks/day

>0.8 drinks/day


0.65

0.67

0.67

NS
Holbrook et al. (Rancho Bernando), 1993 (13)182 men, mean age 59 yrsfair12 yrsBaseline and year 12femoral neck BMDAge, smoking, BMI, exerciseχ2
0 drinks/day

<0.9 drinks/day

0.9–1.8 drinks/day

>1.8 drinks/day


0.68

0.72

0.78

0.75

<0.01 for trend
Felson et al. (Framingham Study), 1995 (12)1,154 adults, aged 68–96 yrs (data shown for men)fair20 yrsBaseline and years 2, 4, 6, 8, 10, 12, 14, and 16femoral neck BMDAge, smoking, weight, heightχ2
<0.2 drinks/day

0.2–0.4 drinks/day

0.7–1.4 drinks/day

1.7–2.9 drinks/day

≥3 drinks/day


0.86

0.86

0.88

0.85

0.88

NS

Incomplete adjustment for potential confounders (age, body mass index, smoking, dietary calcium, physical activity, and estrogen exposure in women); NS indicates “not significant”. BMD indicates bone mineral density; BMI indicates body mass index; “Former drinkers” defined as participants who reported abstinence at baseline but at a follow-up visit responded “yes” to either a “change in pattern of drinking in the past 5 years” or “ever regularly consumed ≥5 drinks daily”.

Gaps in categories due to conversion from drinks per week to drinks per day.

  • View full-size image.
  • Figure 3. 

    Association between alcohol consumption and adjusted femoral neck bone mineral density. Adjustment for confounders is variable. Study adjusting for the fewest covariates controlled for age, smoking, weight, and height. Study adjusting for the most covariates also controlled for leisure time physical activity, difficulty arising from a bed or chair, estrogen therapy, thiazide-type diuretics, thyroid agents, race, diabetes, hypertension, cardiovascular disease, visual problems, arthritis, previous cancer, weight in early teens, and Mini-Mental Status Exam score.

Alcohol Consumption and Bone Density Loss Over Time 

Four prospective cohort studies22, 46, 47, 48 and 1 nested case-control study45 examined the association between alcohol consumption and bone density loss over time (Table 3).44, 45, 46, 47, 48 Two of the 3 studies that reported sex-stratified results found that the pattern of association between alcohol consumption and bone density loss was different in men and women.46, 47

Table 3. Studies of the Association between Alcohol Consumption and Bone Mineral Density Loss Over Time
Study, YearSample CharacteristicsStudy QualityDuration of Follow-upMeasurement of Alcohol ConsumptionOutcome (Unit)Potential Confounders Adjusted for in AnalysisStatistical Measure of AssociationUnit of Analysis of AlcoholBMD LossMagnitude of Associationp Value
BMD loss at the femoral neck among women
Dennison et al. 1999 (46)143 women, aged 60–75 yrsfair4 yrsBaseline and year 4Annual BMD loss at the femoral neckAge, smoking, BMI, change in BMI, activity, calcium intake, osteoarthritis gradeBeta-coefficientper 0.1 drinks/dayNA(−0.07)0.007
Rejnmark et al. (Danish Osteoporosis Prevention Study), 2004 (45)932 women, mean age 49 yrsfair5 yrsBaselineBMD loss at the femoral neck (g/cm2)Age, smoking, weight, waist to hip ratio, time since menopause, est rogen therapy, total energy, calcium, vitamin D intake, metabolic markers of metabolismBeta-coefficientper gram of alcohol/dayNA(−0.048)p < 0.001
Macdonald et al. 2004 (22)891 women, aged 45–55 yrsfair5–7 yrsBaseline and year 5Annual BMD loss at the femoral neck (%/yr)Age, smoking, height, weight, weight change, BMD, activity, activity change, menopausal status, estrogen therapy, socioeconomic status, consuming a weight-reducing diet, osteoarthritisBeta-coefficient
per quartile (medians)

0 drinks/day

0.2 drinks/day

0.5 drinks/day

1.0 drinks/day

NA(−0.0893)0.002
Burger et al. (Rotterdam Study), 1998 (47)2452 women, mean age 67 yrsfairmedian 1.9 yrsBaselineAnnual BMD loss at the femoral neck (g/cm2/yr)Age, smoking, BMI, calcium and energy intake, lower limb disabilityBe ta-coefficient
0 drinks/d

0–<0.7 drinks/day

0.7–<1.4 drinks/day

>=1.4 drinks/day


0.0056

0.0042

0.0051

0.0027

NRNS
Hannan et al. (Framingham Osteoporosis Study), 2000 (48)486 women, aged 67–90 yrsfair4 yrsBaselinePercent BMD loss at the femoral neck (%)Age, smoking, weight, weight change, height, estrogen therapyLeast sq uares mean
0–<0.2 drinks/day

0.2–0.7 drinks/day

>0.7–1.7 drinks/day

>1.7 drinks/day


2.39

2.05

2.28

3.09

NRNS
BMD loss at the femoral neck among men
Burger et al. (Rotterdam Study), 1998 (47)1856 men, mean age 67 yrsfairmedian 1.9 yrsBaselineAnnual BMD loss at the femoral neck (g/cm2/yr)Age, smoking, BMI, calcium and energy intake, lower limb disabilityBeta-coefficient
0 drinks/day

0–<0.7 drinks/day

0.7–<1.4 drinks/day

>=1.4 drinks/day


0.0057

0.0025

0.0012

0.0048

NRNS
Hannan et al. (Framingham Osteoporosis Study), 2000 (48)278 men, aged 67–90 yrsfair4 yrsBaselinePercent BMD loss at the femoral neck (%)Age, smoking, weight, weight change, heightLeast squares mean
0–<0.2 drinks/day

0.2–0.7 drinks/day

>0.7–1.7 drinks/day

>1.7 drinks/day


2.68

2.66

2.57

3.27

NRNS
Dennison et al. 1999 (46)173 men, aged 60–75 yrsfair4 yrsBaseline and year 4BMD loss at the femoral neck (%/yr)Age, smoking, BMI, change in BMI, activity, calcium intake, osteoarthritis gradeBeta-coefficientper 0.1 drinks/dayNANRNS

Incomplete adjustment for potential confounders (age, body mass index, smoking, dietary calcium, physical activity, and estrogen exposure in women).

alcohol consumption measured at baseline only.

1 survey item to measure alcohol consumption or poor explanation of measurement methods. BMD indicated bone mineral density; BMI indicates body mass index; NS indicates not significant; NR indicates not reported.

Bone Density Loss Over Time in Women 

Four of the 5 studies that examined alcohol consumption and bone density loss over time in women found that women with greater alcohol consumption had lower bone density loss.21, 45, 46, 47, 48 Of the 5 studies, 2 studies measured alcohol consumption continuously and found a significant inverse linear association between alcohol consumption and bone density loss.45, 46 Two other studies measured alcohol consumption categorically and found the lowest bone density loss among women with the greatest alcohol consumption (approximately 1-2 drinks per day).22, 47 The final study found a U-shaped relationship between alcohol consumption and bone density loss, with the lowest bone density loss among women consuming 0.2 to 1.7 drinks per day and higher bone density loss among both abstainers and women consuming more than 1.7 drinks per day.48

Bone Density Loss Over Time in Men 

Of the 3 studies that assessed alcohol consumption and bone density loss over time in men, 2 reported U-shaped relationships.47, 48 The lowest bone density loss was among men in the middle drinking categories (between 0.7 and either 1.4 or 1.7 drinks per day), and higher bone density loss was among men with either little or no alcohol consumption and men with the greatest alcohol consumption (at least 1.4 or 1.7 drinks per day). The third study found no linear relationship between continuous alcohol consumption and bone density loss in men.46

Alcohol Consumption and Bone Response to Estrogen Replacement 

Two studies assessed the effect of alcohol consumption on bone response to estrogen therapy. One prospective cohort study found that estrogen therapy was independently associated with a 74% lower risk of hip fracture (RR 0.36 [95% CI, 0.14-0.90]) among women who consumed 1 drink or more per day, compared with abstainers.49 The other was a nested case-control study that defined cases (“good” responders) as women who gained more bone density during 5 years of follow-up than the upper 95th percentile of an untreated group.45 After adjustment for multiple potential confounders, alcohol intake was independently associated with being a “good” responder to estrogen therapy.

Alcohol Consumption and Markers of Bone Remodeling 

Markers of Bone Formation 

Osteocalcin, a vitamin K-dependent protein synthesized by osteoblasts, is widely used as a clinical marker of bone formation. In 6 experimental studies of heavy drinkers (7-16 drinks per day), the subjects served as their own controls. Osteocalcin levels were measured before and after periods of abstinence ranging from 7 days to 2 years.8, 50, 51, 52, 53, 54 All studies found that osteocalcin increased significantly after abstinence.

Two additional experimental studies found consistent results after administering alcohol to healthy male adults.55, 56 The doses of alcohol varied from 1.8 drinks given over 45 minutes55 to 4 drinks administered daily for 3 weeks.56 Both studies found a significant decrease in osteocalcin levels during alcohol administration.

Three of the abstinence studies also examined changes in carboxy-terminal propeptide of type I procollagen,8, 52, 54 a protein representing synthesis of type-1 collagen. All found a significant increase in carboxy-terminal propeptide of type I procollagen during abstinence.

Markers of Bone Resorption 

Hydroxyproline, a modified amino acid that is released during the breakdown of collagen, was measured in 3 studies of heavy drinkers. During abstinence from alcohol, 1 study found a significant increase in urinary hydroxyproline,54 and 2 studies found no significant change.8, 53

Back to Article Outline

Discussion 

Our analysis demonstrates a J-shaped relationship between alcohol consumption and hip fracture risk, with persons consuming up to 1 drink per day having the lowest risk of hip fracture. In contrast, most data on alcohol consumption and bone density suggest a linear association between greater alcohol consumption and both higher bone density and lower bone density loss over time. Studies evaluating hip fracture risk included subjects with greater alcohol consumption than studies evaluating bone density, which may explain why the association between alcohol consumption and hip fracture was J-shaped rather than linear. Because studies of alcohol consumption and bone density included few heavier drinkers, current evidence is insufficient to determine a precise amount of alcohol consumption that is associated with higher bone density.

Compared with abstainers, moderate drinkers had lower hip fracture risk and heavier drinkers had higher hip fracture risk. However, important biases may have influenced these results. It is likely that falls contributed to the observed increase in hip fracture risk among heavier drinkers. Further, most categories of nondrinkers included both lifetime abstainers and former drinkers. If former drinkers stopped for health reasons, this may partially explain the higher hip fracture risk among nondrinkers.

In contrast with the J-shaped association between alcohol consumption and hip fracture risk, pooled data suggest a linear relationship between alcohol consumption and bone density. These data were derived from studies mainly of individuals consuming less than 2 drinks per day. Because these studies may have been underpowered to demonstrate changes in bone density at greater alcohol consumption levels, the observed linear association may not fully describe this relationship. In addition, the increase in bone density associated with each additional drink per day was small in magnitude and of uncertain clinical significance.

The exact mechanism by which alcohol influences bone density is not clear. Putative biological mechanisms for a beneficial effect of alcohol on bone density include increases in the concentration of serum estradiol57, 58 and liver estrogen receptors.59 However, as has been suggested regarding other beneficial effects of moderate alcohol consumption, the observed benefit may reflect confounding by unmeasured healthy behaviors.60, 61 An important limitation of the existing literature, and the reason most studies were rated “fair,” is that few studies sufficiently adjusted for major potential confounders, and none included markers of socioeconomic status. Although our finding that alcohol consumption augments the benefits of estrogen therapy is based on a small number of studies, it is consistent with research suggesting that alcohol ingestion leads to elevations in circulating estradiol levels in women taking estrogen replacement therapy.62, 63, 64 Because of this association, studies that did not control for estrogen exposure may be particularly vulnerable to bias.

Most studies of bone density loss in women demonstrated an inverse linear relationship between alcohol consumption and bone density loss over time, whereas most studies in men reported a J-shaped relationship. Although sex differences in the effect of alcohol consumption on bone density have been suggested,65 observed differences might be explained by differences in alcohol exposure. Studies of bone density loss over time frequently combined moderate and heavy drinkers in a single category, making the greatest drinking category heterogeneous. For example, if the population of women categorized as consuming more than 1.4 drinks per day consumed less alcohol than men in the same drinking category, data from men and women would suggest different patterns of association between alcohol consumption and bone density due partly to misclassification. Further research is needed to characterize sex differences in the effect of alcohol on bone density loss over time.

Data from experimental studies indicate that osteocalcin increases after abstinence and decreases after alcohol administration. These results suggest a reversible suppression of bone formation when administered rapidly or in large doses, and are consistent with prior research.66, 67 The effect of long-term alcohol consumption on bone remodeling likely involves a complex uncoupling of formation and resorption.68 Heavy alcohol consumption may have a direct acute negative effect on osteoblasts, but positive effects of alcohol on bone density may be due to indirect long-term hormonal effects.69 The precise effects of moderate alcohol consumption on bone metabolism are still unknown.

A key limitation of many original studies in this review was the method and timing of alcohol consumption measurement, a weakness that has been noted by other reviews and meta-analyses of alcohol consumption.29, 70, 71 Studies that measured alcohol consumption only at baseline are vulnerable to misclassification if exposure to alcohol changed before the outcome was measured. In addition, collecting data on alcohol consumption by self-report using simple surveys may lead to underreporting, particularly among heavy drinkers.72, 73 Despite this potential reporting bias, the rank order of alcohol consumption reported by individual studies is unlikely to be affected.

Because most included studies were observational, these results must be interpreted with caution. Although many benefits, including decreased mortality,74 have been attributed to moderate alcohol consumption, the appropriateness of using nondrinkers as a reference group has been questioned.75, 76 To expand our understanding of the effects of alcohol on bone density, rigorous prospective studies are needed that carefully measure potential confounders. Because bone density reflects the cumulative effects of numerous factors on bone metabolism over long periods of time, future studies should adjust for baseline bone density.

Back to Article Outline

Conclusions 

Current best evidence on the effect of alcohol on bone density suggests that compared with abstinence, consumption of up to 1 drink per day is associated with a decreased risk of osteoporotic hip fracture. Further, most evidence supports a beneficial effect of moderate alcohol consumption on bone density. However, evidence is insufficient to determine relative associations between alcohol consumption and bone density in moderate compared with heavy drinkers.

Back to Article Outline

Acknowledgments 

The authors thank Racheline G. Habousha, MSLS, AHIP, for assistance with the literature search and David Hamerman, MD, for guidance with article selection criteria.

Back to Article Outline

Appendix 

Appendix. Medical Subject Headings and Text Words Used in Literature Search
ConceptMeSH TermsText Words
Alcohol Consumption
Alcohol-related disorders

Alcoholism

Alcoholic beverages

Alcohol drinking

Alcohol, alcoholic, alcoholism, beer, wine, liquor
Bone Mineral Density
Osteoporosis

Postmenopausal osteoporosis

Bone density Metabolic bone diseases

Pathologic bone demineralization

Osteoporosis, osteopenia, bone mineral density, BMD, bone resorption
Osteoporotic Fractures
Fractures

Spontaneous fractures

Hip fracture

Spinal fractures

Wrist injuries

Compression fracture, fragility fracture, atraumatic fracture
MetabolismBone resorptionTelopeptide, n-telopeptide, c-telopeptide, osteocalcin, bone-Gla protein, BGP, bone and alkaline phosphatase, deoxypyridinoline, hydroxyproline, tartrate-resistant acid phosphatase, TRACP, bone and sialoprotein, hydroxylysine

BMD, Bone mineral density; BGP, beta-glycerophosphatase; TRACP, tartrate-resistant acid phosphatase.

Back to Article Outline

References 

  1. Advocacy News and Updates. Washington DC. National Osteoporosis Foundation. http://www.nof.org/advocacy/prevalence/index.htmAccessed June 28, 2007
  2. Osteoporosis Disease Facts. Washington DC. National Osteoporosis Foundation. http://www.nof.org/osteoporosis/diseasefacts.htmAccessed June 28, 2007
  3. Spencer H, Rubio N, Rubio E, et al. Chronic alcoholism (Frequently overlooked cause of osteoporosis in men). Am J Med. 1986;80:393–397
  4. Bikle DD, Genant HK, Cann C, et al. Bone disease in alcohol abuse. Ann Intern Med. 1985;103:42–48
  5. Lalor BC, France MW, Powell D, et al. Bone and mineral metabolism and chronic alcohol abuse. Q J Med. 1986;59:497–511
  6. Feitelberg S, Epstein S, Ismail F, D'Amanda C. Deranged bone mineral metabolism in chronic alcoholism. Metab Clin Exp. 1987;36:322–326
  7. Chon KS, Sartoris DJ, Brown SA, Clopton P. Alcoholism-associated spinal and femoral bone loss in abstinent male alcoholics, as measured by dual X-ray absorptiometry. Skeletal Radiol. 1992;21:431–436
  8. Laitinen K, Karkkainen M, Lalla M, et al. Is alcohol an osteoporosis-inducing agent for young and middle-aged women?. Metab Clin Exp. 1993;42:875–881
  9. Williams FM, Cherkas LF, Spector TD, MacGregor AJ. The effect of moderate alcohol consumption on bone mineral density: a study of female twins. Ann Rheum Dis. 2005;64:309–310
  10. Nguyen TV, Kelly PJ, Sambrook PN, et al. Lifestyle factors and bone density in the elderly: implications for osteoporosis prevention. J Bone Miner Res. 1994;9:1339–1346
  11. Orwoll ES, Bauer DC, Vogt TM, Fox KM. Axial bone mass in older women (Study of Osteoporotic Fractures Research Group). Ann Intern Med. 1996;124:187–196
  12. Felson DT, Zhang Y, Hannan MT, et al. Alcohol intake and bone mineral density in elderly men and women (The Framingham Study). Am J Epidemiol. 1995;142:485–492
  13. Holbrook TL, Barrett-Connor E. A prospective study of alcohol consumption and bone mineral density. BMJ. 1993;306:1506–1509
  14. May H, Murphy S, Khaw KT. Alcohol consumption and bone mineral density in older men. Gerontology. 1995;41:152–158
  15. Cauley JA, Fullman RL, Stone KL, et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int. 2005;16:1525–1537
  16. Feskanich D, Korrick SA, Greenspan SL, et al. Moderate alcohol consumption and bone density among postmenopausal women. J Womens Health. 1999;8:65–73
  17. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Potential risk factors for development of postmenopausal osteoporosis--examined over a 12-year period. Osteoporos Int. 1991;1:95–102
  18. Laitinen K, Valimaki M, Keto P. Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women. Calcif Tissue Int. 1991;48:224–231
  19. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–795
  20. Harris RP, Helfand M, Woolf SH, et al. Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 Suppl):21–35
  21. Baron JA, Farahmand BY, Weiderpass E, et al. Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med. 2001;161:983–988
  22. Macdonald HM, New SA, Golden MH, et al. Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr. 2004;79:155–165
  23. Description for standard drinks chart. National Institute on Alcohol Abuse and Alcoholism, U.S. Dept of Health and Human Services; 2005. http://pubs.niaaa.nih.gov/publications/Practitioner/PocketGuide/pocket_guide2.htmAccessed June 28, 2007
  24. Alcohol. Better Health Channel. Melbourne Australia; 1999. www.betterhealth.vic.gov.au/BHCV2/bhcarticles.nsf/pages/AlcoholAccessed June 28, 2007
  25. Difficulties in measuring drinking levels. DrugsAlcohol.info, Health Promotion Agency. http://www.drugsalcohol.info/alcohol/default.asp?artId = 45Accessed June 28, 2007
  26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  27. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–1309
  28. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769–773
  29. Koppes LL, Dekker JM, Hendriks HF, et al. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719–725
  30. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  31. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for hip fracture in black women (The Northeast Hip Fracture Study Group). N Engl J Med. 1994;330:1555–1559
  32. Suzuki T, Yoshida H, Hashimoto T, et al. Case-control study of risk factors for hip fractures in the Japanese elderly by a Mediterranean Osteoporosis Study (MEDOS) questionnaire. Bone. 1997;21:461–467
  33. Mukamal KJ, Robbins JA, Cauley JA, et al. Alcohol consumption, bone density, and hip fracture among older adults: the cardiovascular health study. Osteoporos Int. 2007;18:593–602
  34. Felson DT, Kiel DP, Anderson JJ, Kannel WB. Alcohol consumption and hip fractures: the Framingham Study. Am J Epidemiol. 1988;128:1102–1110
  35. Hoidrup S, Gronbaek M, Gottschau A, et al. Alcohol intake, beverage preference, and risk of hip fracture in men and women (Copenhagen Centre for Prospective Population Studies). Am J Epidemiol. 1999;149:993–1001
  36. Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int. 2004;16:799–804
  37. Holbrook TL, Barrett-Connor E, Wingard DL. Dietary calcium and risk of hip fracture: 14-year prospective population study. Lancet. 1988;2:1046–1049
  38. Hemenway D, Azrael DR, Rimm EB, et al. Risk factors for hip fracture in U.S. men aged 40 through 75 years. Am J Public Health. 1994;84:1843–1845
  39. Hernandez-Avila M, Colditz GA, Stampfer MJ, et al. Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women. Am J Clin Nutr. 1991;54:157–163
  40. Hansen SA, Folsom AR, Kushi LH, Sellers TA. Association of fractures with caffeine and alcohol in postmenopausal women: the Iowa Women's Health Study. Public Health Nutr. 2000;3:253–261
  41. Cumming RG, Klineberg RJ. Case-control study of risk factors for hip fractures in the elderly. Am J Epidemiol. 1994;139:493–503
  42. La Vecchia C, Negri E, Levi F, Baron JA. Cigarette smoking, body mass and other risk factors for fractures of the hip in women. Int J Epidemiol. 1991;20:671–677
  43. Hemenway D, Azrael DR, Rimm EB, et al. Risk factors for wrist fracture: effect of age, cigarettes, alcohol, body height, relative weight, and handedness on the risk for distal forearm fractures in men. Am J Epidemiol. 1994;140:361–367
  44. Samelson EJ, Hannan MT, Zhang Y, et al. Incidence and risk factors for vertebral fracture in women and men: 25-year follow-up results from the populations-based Framingham study. J Bone Miner Res. 2006;21:1207–1214
  45. Rejnmark L, Vestergaard P, Tofteng CL, et al. Response rates to oestrogen treatment in perimenopausal women: 5-year data from the Danish Osteoporosis Prevention Study (DOPS). Maturitas. 2004;48:307–320
  46. Dennison E, Eastell R, Fall CH, et al. Determinants of bone loss in elderly men and women: a prospective population-based study. Osteoporos Int. 1999;10:384–391
  47. Burger H, de Laet CE, van Daele PL, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol. 1998;147:871–879
  48. Hannan MT, Felson DT, Dawson-Hughes B, et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Min Res. 2000;15:710–720
  49. Hoidrup S, Gronbaek M, Pedersen AT, Lauritzen JB, Gottschau A, Schroll M. Hormone replacement therapy and hip fracture risk: effect modification by tobacco smoking, alcohol intake, physical activity, and body mass index. Am J Epidemiol. 1999;150:1085–1093
  50. Peris P, Pares A, Guanabens N, et al. Bone mass improves in alcoholics after 2 years of abstinence. J Bone Miner Res. 1994;9:1607–1612
  51. Gonzalez-Calvin JL, Garcia-Sanchez A, Bellot V, et al. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol. 1993;28:571–579
  52. Nyquist F, Ljunghall S, Berglund M, Obrant K. Biochemical markers of bone metabolism after short and long time ethanol withdrawal in alcoholics. Bone. 1996;19:51–54
  53. Pepersack T, Fuss M, Otero J, et al. Longitudinal study of bone metabolism after ethanol withdrawal in alcoholic patients. J Bone Miner Res. 1992;7:383
  54. Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Bone mineral density and abstention-induced changes in bone and mineral metabolism in noncirrhotic male alcoholics. Am J Med. 1992;93:642–650
  55. Garcia-Sanchez A, Gonzalez-Calvin JL, Diez-Ruiz A, et al. Effect of acute alcohol ingestion on mineral metabolism and osteoblastic function. Alcohol Alcohol. 1995;30:449–453
  56. Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Effects of 3 weeks' moderate alcohol intake on bone and mineral metabolism in normal men. Bone Miner. 1991;13:139–151
  57. Gavaler JS, Van Thiel DH. The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal post-menopausal women: relationship to the literature. Alcohol Clin Exp Res. 1992;16:87
  58. Gavaler JS. Oral hormone replacement therapy: factors that influence the estradiol concentrations achieved in a multiracial study population. J Clin Pharmacol. 2002;42:137–144
  59. Chung KW. Effects of chronic ethanol intake on aromatization of androgens and concentration of estrogen and androgen receptors in rat liver. Toxicology. 1990;62:285–295
  60. Rimm EB. Alcohol consumption and coronary heart disease: good habits may be more important than just good wine. Am J Epidemiol. 1996;143:1094–1098
  61. Nielsen NR, Schnohr P, Jensen G, Gronbaek M. Is the relationship between type of alcohol and mortality influenced by socio-economic status?. J Intern Med. 2004;255:280–288
  62. Ginsburg ES, Mello NK, Mendelson JH, et al. Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA. 1996;276:1747–1751
  63. Purohit V. Moderate alcohol consumption and estrogen levels in postmenopausal women: a review. Alcohol Clin Exp Res. 1998;22:994–997
  64. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995;87:1297–1302
  65. Turner RT. Skeletal response to alcohol. Alcohol Clin Exp Res. 2000;24:1693–1701
  66. Klein RF, Fausti KA, Carlos AS. Ethanol inhibits human osteoblastic cell proliferation. Alcohol Clin Exp Res. 1920;572–578
  67. Chavassieux P, Serre CM, Vergnaud P, et al. In vitro evaluation of dose-effects of ethanol on human osteoblastic cells. Bone Miner. 1993;22:95–103
  68. Chakkalakal DA. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res. 2005;29:2077–2090
  69. Sampson HW, Shipley D. Moderate alcohol consumption does not augment bone density in ovariectomized rats. Alcohol Clin Exp Res. 1997;21:1165–1168
  70. Cook RL, Clark DB. Is there an association between alcohol consumption and sexually transmitted diseases? (A systematic review). Sex Transm Dis. 2005;32:156–164
  71. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med. 2004;140:211–219
  72. Koppes LL, Twisk JW, Snel J, Kemper HC. Concurrent validity of alcohol consumption measurement in a ‘healthy’ population; quantity-frequency questionnaire v. dietary history interview. Br J Nutr. 2002;88:427–434
  73. Feunekes GI, van't Veer , van Staveren WA, Kok FJ. Alcohol intake assessment: the sober facts. Am J Epidemiol. 1999;150:105–112
  74. Di Castelnuovo A, Costanzo S, Bagnardi V, et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437–2445
  75. Wannamethee SG, Shaper AG. Lifelong teetotalers, ex-drinkers and drinkers: mortality and the incidence of major coronary heart disease events in middle-aged British men. Int J Epidemiol. 1997;26:523–531
  76. Abdulla S. Is alcohol really good for you?. J R Soc Med. 1997;90:651

 This study was funded by the Program of Research Integrating Substance Use in Mainstream Healthcare with support from the Robert Wood Johnson Foundation, National Institute on Drug Abuse (NIDA), and National Institute on Alcohol Abuse and Alcoholism (co-directors A. T. McLellan, PhD, and B. J. Turner, MD, MSEd). Additional support was provided by grants K23 DA021087 from the NIDA and the National Institute of Mental Health and a Robert Wood Johnson Foundation Physician Faculty Scholar Award to Dr Berg; grants R25 DA14551 and R01 DA015302 from the NIDA to Dr Arnsten; and a Center for AIDS Research grant (P30 AI51519) to the Albert Einstein College of Medicine of Yeshiva University from the National Institutes of Health.

PII: S0002-9343(08)00109-5

doi:10.1016/j.amjmed.2007.12.012

The American Journal of Medicine
Volume 121, Issue 5 , Pages 406-418, May 2008